Company performance
Current Price
as of Jan 17, 2025$2.37
P/E Ratio
N/A
Market Cap
$244.59M
- 9310
Description
ProQR Therapeutics NV is a clinical stage biopharmaceutical company, which engages in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases with a focus on inherited retinal diseases. The company was founded by Daniel Anton de Boer, Gerard J. Platenburg, Henri A. Termeer, and Domenico Valerio on February 21, 2012, and is headquartered in Leiden, the Netherlands.
Metrics
Overview
- HQLeiden, ZH
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerPRQR
- Price$2.37+3.04%
Trading Information
- Market cap$244.59M
- Float71.97%
- Average Daily Volume (1m)292,808
- Average Daily Volume (3m)621,022
- EPS-$0.32
Company
- Revenue$19.37M
- Rev growth (1yr)183.27%
- Net income-$8.91M
- Gross margin82.10%
- EBITDA margin-212.49%
- EBITDA-$8.97M
- EV$66.50M
- EV/Revenue3.43
- P/EN/A
- P/S9.99
- P/B6.94